Omran Saifi, MD (@omransaifi) 's Twitter Profile
Omran Saifi, MD

@omransaifi

Chief Radiation Oncology Resident @MayoClinic šŸ”œ Faculty @MDAndersonNews | MD '20 @AUB_Lebanon | Interests: Radiation, CAR-T, lymphoma

ID: 1242176677310074882

calendar_today23-03-2020 19:50:21

279 Tweet

954 Followers

887 Following

Colton Ladbury, MD (@coltonladbury) 's Twitter Profile Photo

Omran Saifi, MD made a beautiful and compelling case for use of bridging radiation, particularly in patients with 2 or fewer sites of active disease. #ASTRO24

<a href="/OmranSaifi/">Omran Saifi, MD</a> made a beautiful and compelling case for use of bridging radiation, particularly in patients with 2 or fewer sites of active disease. #ASTRO24
Colton Ladbury, MD (@coltonladbury) 's Twitter Profile Photo

Unfortunately unsurprising but very important data from Omran Saifi, MD illustrating need to advocate for our specialty to have more seats in national lymphoma guideline committees, research groups, and academic journals #ASTRO24

Unfortunately unsurprising but very important data from <a href="/OmranSaifi/">Omran Saifi, MD</a> illustrating need to advocate for our specialty to have more seats in national lymphoma guideline committees, research groups, and academic journals #ASTRO24
The Lancet Haematology (@thelancethaem) 's Twitter Profile Photo

NEW Viewpoint—#Radiation target nomenclature for #lymphoma trials: consensus recommendations from the National Clinical Trials Network groups #radonc #lymsm thelancet.com/journals/lanha…

Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

Sadly, this isn’t surprising. Radiation oncology continues to be overlooked in National Comprehensive Cancer Network (NCCN) lymphoma committees, research cooperative groups, research foundations, and hematology editorial boards. It’s no wonder so many patients reach CAR-T or ASCT without ever receiving radiotherapy.

Omran Saifi, MD (@omransaifi) 's Twitter Profile Photo

Published alongside our ASTRO prsntation, bridging RT significantly improves outcomes for pts with limited (<5 sites) pre-CART disease, esp comprehensively, compared to no bridging RT or bridging systemic tx: ā¬†ļøDurable CR ā¬‡ļøLocal relapse ā¬†ļøRelapse and event-free survivals

Omran Saifi, MD (@omransaifi) 's Twitter Profile Photo

šŸ’”Reminder: Contemporary #radiotherapy for #lymphoma has evolved significantly! Radiation fields are much SMALLER, doses are LOWER, and techniques are more CONFORMAL—resulting in much LOWER toxicity while still achieving significant improvements in PFS! doi.org/10.1053/j.semi…

šŸ’”Reminder: Contemporary #radiotherapy for #lymphoma has evolved significantly! Radiation fields are much SMALLER, doses are LOWER, and techniques are more CONFORMAL—resulting in much LOWER toxicity while still achieving significant improvements in PFS!  

doi.org/10.1053/j.semi…
Radiation Oncology Institute-The ASTRO Foundation (@ro_institute) 's Twitter Profile Photo

On the 3rd day of #gRADitude2024, ROI shared with me... the opportunity to celebrate exceptional contributions from early career investigators. Congratulations to Jie Jane Chen, MD, Omran Saifi, MD, and Felix Ehret for winning the 2024 ROI Publication Excellence Awards!

On the 3rd day of #gRADitude2024, ROI shared with me... the opportunity to celebrate exceptional contributions from early career investigators.  Congratulations to <a href="/JieJaneChen/">Jie Jane Chen, MD</a>, <a href="/OmranSaifi/">Omran Saifi, MD</a>, and <a href="/FelixEhretMD/">Felix Ehret</a> for winning the 2024 ROI Publication Excellence Awards!
IACH (@theiach) 's Twitter Profile Photo

šŸŽ™ļø Tune in to the latest IACH News podcast featuring Dr. Omran Saifi Outcomes of Patients with R/R B-Cell NHL and Limited (<5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy iach.org/iach-news-podc… Omran Saifi, MD Mohamad Mohty

šŸŽ™ļø Tune in to the latest <a href="/TheIACH/">IACH</a> News podcast featuring Dr. Omran Saifi

Outcomes of Patients with R/R B-Cell NHL and Limited (&lt;5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy

iach.org/iach-news-podc…

<a href="/OmranSaifi/">Omran Saifi, MD</a> <a href="/Mohty_EBMT/">Mohamad Mohty</a>
OncoDaily (@oncodaily) 's Twitter Profile Photo

šŸŽ™ļøIACH's (IACH) new podcast with Omran Saifi (Omran Saifi, MD) oncodaily.com/url/212909 #Cancer #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Mohamed Kharfan-Dabaja, MD, MBA (@mkd_bmt) 's Twitter Profile Photo

The largest experience of autologous hematopoietic cell transplantation in 1700 patients with autoimmune diseases, in the outpatient setting, using the ā€œMexican methodā€. ā€œYes, it can be doneā€ ā€œSi se puedeā€Bone Marrow Transplantation Guillermo J. Ruiz-Argüelles David Gómez-Almaguer Andres Gomez

The largest experience of autologous hematopoietic cell transplantation in 1700 patients with autoimmune diseases, in the outpatient setting, using the ā€œMexican methodā€.  ā€œYes, it can be doneā€ ā€œSi se puedeā€<a href="/BMTjournal/">Bone Marrow Transplantation</a> <a href="/GuillermoRuizA5/">Guillermo J. Ruiz-Argüelles</a> <a href="/dgomezalmaguer/">David Gómez-Almaguer</a> <a href="/GomezDLeonMD/">Andres Gomez</a>
Omran Saifi, MD (@omransaifi) 's Twitter Profile Photo

Our NRG Oncology HemeGroup #RadiateEquity initiative The Lancet Haematology āž”ļøRadOncs are underrepresented in lymphoma NCCN committees, cooperative groups, research foundations and heme journals editorial boards Multi-D improves pts outcomes! Bradford Hoppe Chelsea C Pinnix MD PhD doi.org/10.1016/S2352-…

Bradford Hoppe (@hoppebrad) 's Twitter Profile Photo

Radiate equity: the inclusion of radiation oncology and other specialt... sciencedirect.com/science/articl… RT still has an important role in lymphoma, especially using smaller fields & cutting edge tech. Let’s make sure Rad Oncs have a seat at the table. NRG Oncology ILROG Team

Radiation Oncology Institute-The ASTRO Foundation (@ro_institute) 's Twitter Profile Photo

Is 2025 YOUR year to win a Publication Excellence Award? Nominate yourself or a colleague at bit.ly/2025_PEA_nomin… to be recognized at the ASTRO Annual Meeting and win $1,500. Also accepting nominations for the ARRO Health Care Access Publication Award. #radonc

Is 2025 YOUR year to win a Publication Excellence Award? Nominate yourself or a colleague at bit.ly/2025_PEA_nomin… to be recognized at the <a href="/ASTRO_org/">ASTRO</a> Annual Meeting and win $1,500. Also accepting nominations for the <a href="/ARRO_org/">ARRO</a> Health Care Access Publication Award. #radonc